Exagen Inc.
XGN • NASDAQ
Exagen Inc. is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO John Aballi, with a market cap of $64.5M.
CEOJohn Aballi
Next Earnings
Upcoming earnings announcement for Exagen Inc.
Date
Monday, May 4, 2026 (in a month)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.23
Revenue Estimate
$16.6M
Earnings History
Past 12 earnings reports for Exagen Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 10, 2026 | Q4 2025 | -$0.20Est: -$0.20 | 0.0% | $16.6MEst: $16.5M | +0.8% |  10-K |
| Nov 4, 2025 | Q3 2025 | -$0.19Est: -$0.15 | -26.7% | $17.2MEst: $17.0M | +1.4% | 10-Q |
| Jul 29, 2025 | Q2 2025 | -$0.18Est: -$0.16 | -12.5% | $17.2MEst: $16.2M | +6.3% | 10-Q |
| May 5, 2025 | Q1 2025 | -$0.20Est: -$0.21 | +4.8% | $15.5MEst: $14.6M | +6.5% | 10-Q |
| Mar 11, 2025 | Q4 2024 | -$0.20Est: -$0.24 | +16.7% | $13.7MEst: $13.9M | -1.4% | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.28Est: -$0.29 | +3.4% | $12.5MEst: $13.6M | -7.8% | 10-Q |
| Aug 5, 2024 | Q2 2024 | -$0.16Est: -$0.35 | +54.3% | $15.1MEst: $13.1M | +14.7% | 10-Q |
| May 13, 2024 | Q1 2024 | -$0.19Est: -$0.36 | +47.2% | $14.4MEst: $13.1M | +10.1% | 10-Q |
| Mar 18, 2024 | Q4 2023 | -$0.31Est: -$0.43 | +27.9% | $13.8MEst: $11.6M | +19.1% | 10-K |
| Nov 13, 2023 | Q3 2023 | -$0.31Est: -$0.46 | +32.6% | $13.4MEst: $10.3M | +29.9% | — |
| Aug 7, 2023 | Q2 2023 | -$0.28Est: -$0.48 | +41.7% | $14.1MEst: $11.0M | +28.9% | 10-Q |
| May 15, 2023 | Q1 2023 | -$0.44Est: -$0.56 | +21.4% | $11.2MEst: $9.4M | +19.5% | — |